Phenomix Sciences Launches First-of-its-Kind Test to Predict Obesity Phenotype Resulting in Precision Medicine Treatment Options
Pneumeric™ Inc., Medical Device Manufacturer of the Capnospot™, Receives FDA 510(k) Clearance with Superiority Claim
New Study Demonstrates the Effectiveness of a Phenotype-Tailored Lifestyle Intervention on Weight Loss
OpSens Appoints John Hannigan as Chief Financial Officer